Platelets release mitochondrial antigens in systemic lupus erythematosus
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Platelets are a source of extracellular DNA and mitochondrial antigens in systemic lupus erythematosus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The plasma of patients with SLE contains elevated levels of extracellular vesicle-containing immune complexes compared with healthy individuals, the presence of which is associated with anti-dsDNA antibodies, pro-inflammatory cytokines and disease activity213–217.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [214]
In the citing paper
“In a similar fashion, numerous stimuli, including immune complexes and their combination with TLR ligands, are able to induce platelet activation and subsequent release of extracellular mitochondria214,215.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [214]
In the citing paper
“Data from transgenic animals and mice with fluorescently labelled mitochondria suggest that, in models of SLE, platelets are a notable source of mtDNA, most of which is contained in naked mitochondria214.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [214]
In the citing paper
“Intriguingly, most of the mtDNA present in the plasma of patients with SLE originates from naked mitochondria214.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [214]
In the citing paper
“Because of their number, platelets are the main reservoir of mitochondria in the blood, and thus the principal source of extracellular mitochondria214.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [214]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996 · cited 3×
“Once internalized by cells, these mitochondria may activate intracellular DNA sensors (12, 13).”
BackgroundNovel cell death program leads to neutrophil extracellular traps
Fuchs, T. A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., Weinrauch, Y., Brinkmann, V., & Zychlinsky, A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200606027 · Cited by 3,197
Gladman, D., Ginzler, E., Goldsmith, C., Fortin, P., Liang, M., Sanchez‐Guerrero, J., Urowitz, M., Bacon, P., Bombardieri, S., Hanly, J., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390303 · Cited by 2,582
Self-citationChromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Lood, C., Blanco, L. P., Purmalek, M. M., Carmona-Rivera, C., De Ravin, S. S., Smith, C. K., Malech, H. L., Ledbetter, J. A., Elkon, K. B., & Kaplan, M. J. (2016) · Nature Medicine · doi:10.1038/nm.4027 · Cited by 1,570
Self-citationMitochondria in innate immune responses
West, A. P., Shadel, G. S., & Ghosh, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri2975 · Cited by 1,376
New insights into the immunopathogenesis of systemic lupus erythematosus
Tsokos, G. C., Lo, M. S., Reis, P. C., & Sullivan, K. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.186 · Cited by 1,226 · cited 1×
“Although the mechanisms underlying the initiation and progression of the disease are still not well understood, it is currently accepted that the accumulation of autoantibodies and autoantigens (DNA and nucleus components) (2) in blood, the formation of antibody-antigen scaffolds called immune complexes (ICs), and the…”
BackgroundNew mitochondrial DNA synthesis enables NLRP3 inflammasome activation
Zhong, Z., Liang, S., Sanchez-Lopez, E., He, F., Shalapour, S., Lin, X.-J., Wong, J., Ding, S., Seki, E., Schnabl, B., et al. (2018) · Nature · doi:10.1038/s41586-018-0372-z · Cited by 1,208
BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis
McArthur, K., Whitehead, L. W., Heddleston, J. M., Li, L., Padman, B. S., Oorschot, V., Geoghegan, N. D., Chappaz, S., Davidson, S., San Chin, H., et al. (2018) · Science · doi:10.1126/science.aao6047 · Cited by 1,072 · cited 1×
“We further speculate that these mitochondrial particles may be directly released from the herniated mitochondrial membrane in the cytoplasm, as in apoptotic cells (26), and may be secreted concomitantly with granule molecules such as PF4.”
BackgroundThe Human Mitochondrial Transcriptome
Mercer, T. R., Neph, S., Dinger, M. E., Crawford, J., Smith, M. A., Shearwood, A.-M. J., Haugen, E., Bracken, C. P., Rackham, O., Stamatoyannopoulos, J. A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.051 · Cited by 905
The incredible journey: From megakaryocyte development to platelet formation
Machlus, K. R., & Italiano, J. E. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201304054 · Cited by 856 · cited 1×
“FcRIIANull mice and FcRIIATGN hemizygous mice (46) on the C57BL/6J background were obtained from the Jackson laboratory.”
MethodHuman lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Arraud, N., Linares, R., Tan, S., Gounou, C., Pasquet, J. ‐., Mornet, S., & Brisson, A. R. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12554 · Cited by 740
Self-citationBoudreau, L. H., Duchez, A.-C., Cloutier, N., Soulet, D., Martin, N., Bollinger, J., Paré, A., Rousseau, M., Naika, G. S., Lévesque, T., et al. (2014) · Blood · doi:10.1182/blood-2014-05-573543 · Cited by 703
Self-citationTer Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330505 · Cited by 572 · cited 2×
“Anti-DNA antibodies correlate with disease activity and can be identified in kidneys of patients with SLE (6, 8).”
BackgroundBoulé, M. W., Broughton, C., Mackay, F., Akira, S., Marshak-Rothstein, A., & Rifkin, I. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031942 · Cited by 518
Caielli, S., Athale, S., Domic, B., Murat, E., Chandra, M., Banchereau, R., Baisch, J., Phelps, K., Clayton, S., Gong, M., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151876 · Cited by 501 · cited 4×
“Given that mtDNA release by neutrophils is reported to occur concomitantly with NETosis (30, 31), we verified the presence of NETs in the same patients.”
BackgroundInfluentialThe global burden of SLE: prevalence, health disparities and socioeconomic impact
Carter, E. E., Barr, S. G., & Clarke, A. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.137 · Cited by 497
Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus
Al-Mayouf, S. M., Sunker, A., Abdwani, R., Abrawi, S. A., Almurshedi, F., Alhashmi, N., Al Sonbul, A., Sewairi, W., Qari, A., Abdallah, E., et al. (2011) · Nature Genetics · doi:10.1038/ng.975 · Cited by 490
Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity
Sisirak, V., Sally, B., D’Agati, V., Martinez-Ortiz, W., Özçakar, Z. B., David, J., Rashidfarrokhi, A., Yeste, A., Panea, C., Chida, A. S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.034 · Cited by 450 · cited 1×
“Moreover, the deletion of DNASE1L3 in mice leads to accumulation of circulating DNA in extracellular vesicles in blood and to the development of anti-DNA antibodies and SLE-like disease (18).”
BackgroundBarth, E. (1992) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(92)93381-s · Cited by 438
Blood contains circulating cell‐free respiratory competent mitochondria
Al Amir Dache, Z., Otandault, A., Tanos, R., Pastor, B., Meddeb, R., Sanchez, C., Arena, G., Lasorsa, L., Bennett, A., Grange, T., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201901917rr · Cited by 383 · cited 1×
“5 of 14 study suggesting the presence of mtDNA in the blood of healthy individuals (36).”
BackgroundRenal Disease associated with Positive Lupus Erythematosus Tests in a Crossbred Strain of Mice
HELYER, B. J., & HOWIE, J. B. (1963) · Nature · doi:10.1038/197197a0 · Cited by 333 · cited 1×
“Therefore, we introduced FcRIIA into the New Zealand black x New Zealand white (NZB/WF1) SLE model, a model produced by breeding the two autoimmune strains, NZW and NZB, to result in an SLE-prone F1 model that recapitulates many features of human SLE (40).”
MethodFunctional significance of the platelet immune receptors GPVI and CLEC-2
Rayes, J., Watson, S. P., & Nieswandt, B. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122955 · Cited by 328 · cited 1×
“Platelets recruited to the kidneys by FcRIIA recognition of IC may undergo further activation through interactions of CLEC-2 with podoplanin, which is also abundant in the kidney (55).”
BackgroundPuhm, F., Afonyushkin, T., Resch, U., Obermayer, G., Rohde, M., Penz, T., Schuster, M., Wagner, G., Rendeiro, A. F., Melki, I., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.314601 · Cited by 306
Self-citationJoseph, J. E., Harrison, P., Mackie, I. J., Isenberg, D. A., & Machin, S. J. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03101.x · Cited by 262 · cited 2×
“Chronic platelet activation is reported in patients with SLE (22), and given the recognized contribution of circulating DAMPs and IC in cellular activation, we examined their respective role in MitoDsRed+ FcγRIIATGN”
BackgroundThe origin and properties of extracellular DNA: From PAMP to DAMP
Pisetsky, D. S. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.04.006 · Cited by 222
Cloutier, N., Allaeys, I., Marcoux, G., Machlus, K. R., Mailhot, B., Zufferey, A., Levesque, T., Becker, Y., Tessandier, N., Melki, I., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720553115 · Cited by 219
Self-citationThe evolution of human anti-double-stranded DNA autoantibodies
Wellmann, U., Letz, M., Herrmann, M., Angermüller, S., Kalden, J. R., & Winkler, T. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500132102 · Cited by 210 · cited 1×
“Thus, extracellular vesicles convey antigenic DNA in SLE, which, together with sustained type I IFN signaling, can further induce somatic replacement mutation in DNA-reactive B cells and promote generation of high affinity antiDNA antibodies (19).”
BackgroundMcKenzie, S. E., Taylor, S. M., Malladi, P., Yuhan, H., Cassel, D. L., Chien, P., Schwartz, E., Schreiber, A. D., Surrey, S., & Reilly, M. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4311 · Cited by 208
Self-citationT granules in human platelets function in TLR9 organization and signaling
Thon, J. N., Peters, C. G., Machlus, K. R., Aslam, R., Rowley, J., Macleod, H., Devine, M. T., Fuchs, T. A., Weyrich, A. S., Semple, J. W., et al. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201111136 · Cited by 203 · cited 1×
“The stimulation of TLR9, which is exposed on the activated platelet plasma membrane (53), was insufficient to generate extracellular mitochondria.”
BackgroundNouvelle Cuisine: Platelets Served with Inflammation
Kapur, R., Zufferey, A., Boilard, E., & Semple, J. W. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500259 · Cited by 201
Self-citationMcKenzie, S. E., Taylor, S. M., Malladi, P., et al. (1999) · PubMed · Cited by 184
Self-citationSex hormones and systemic lupus erythematosus: Review and meta‐analysis
McMurray, R. W., & May, W. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11105 · Cited by 175
Vogelpoel, L. T. C., Hansen, I. S., Rispens, T., Muller, F. J. M., van Capel, T. M. M., Turina, M. C., Vos, J. B., Baeten, D. L. P., Kapsenberg, M. L., de Jong, E. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms6444 · Cited by 175
Nielsen, C. T., Østergaard, O., Stener, L., Iversen, L. V., Truedsson, L., Gullstrand, B., Jacobsen, S., & Heegaard, N. H. H. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34381 · Cited by 167 · cited 1×
“In SLE, extracellular vesicles liberated by numerous cellular lineages, such as leukocytes and endothelial cells, are elevated in blood (14) and are targeted by antibodies and complement, pointing to their antigenic load (15, 16).”
BackgroundHASUWA, H., MURO, Y., IKAWA, M., KATO, N., TSUJIMOTO, Y., & OKABE, M. (2010) · Experimental Animals · doi:10.1538/expanim.59.105 · Cited by 158 · cited 1×
“Therefore, we took advantage of a reporter mouse with red fluorescent protein (RFP) targeted to the mitochondrion in all cells due to the presence of a mitochondrial import sequence, subunit 9 of the adenosine triphosphatase (42).”
BackgroundOkamura, M., Kanayama, Y., Amastu, K., Negoro, N., Kohda, S., Takeda, T., & Inoue, T. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.1.14 · Cited by 158
The non-haemostatic role of platelets in systemic lupus erythematosus
Linge, P., Fortin, P. R., Lood, C., Bengtsson, A. A., & Boilard, É. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.38 · Cited by 142
Self-citationBreaking Immunological Tolerance in Systemic Lupus Erythematosus
Pieterse, E., & van der Vlag, J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00164 · Cited by 137 · cited 1×
“Apoptotic cells and activated neutrophils have been widely recognized as important sources of circulating autoantigens in SLE (44).”
BackgroundMechanisms of Tissue Injury in Lupus Nephritis
Flores-Mendoza, G., Sansón, S. P., Rodríguez-Castro, S., Crispín, J. C., & Rosetti, F. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.02.003 · Cited by 125 · cited 2×
“INTRODUCTION Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that presents with highly variable symptoms and manifestations, making diagnosis and treatment challenging (1, 2).”
BackgroundIngelsson, B., Söderberg, D., Strid, T., Söderberg, A., Bergh, A.-C., Loitto, V., Lotfi, K., Segelmark, M., Spyrou, G., & Rosén, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711950115 · Cited by 123 · cited 1×
“As mitochondrial organelles bear different copy numbers of their genome, which varies depending on the cellular lineage (48), this suggests that each mitochondrion in platelets may contain fewer copies of the mitochondrial genome than leukocytes, probably because of mitochondrial fission during platelet genesis.”
BackgroundZhang, B., Asadi, S., Weng, Z., Sismanopoulos, N., & Theoharides, T. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049767 · Cited by 121
Unique Protein Signature of Circulating Microparticles in Systemic Lupus Erythematosus
Østergaard, O., Nielsen, C. T., Iversen, L. V., Tanassi, J. T., Knudsen, S., Jacobsen, S., & Heegaard, N. H. H. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38065 · Cited by 110 · cited 1×
“Platelets are highly potent at generating extracellular vesicles when activated, and platelet-derived vesicles are the most abundant vesicles in the blood of healthy individuals and patients with SLE (24).”
BackgroundCooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo
Zhi, H., Rauova, L., Hayes, V., Gao, C., Boylan, B., Newman, D. K., McKenzie, S. E., Cooley, B. C., Poncz, M., & Newman, P. J. (2012) · Blood · doi:10.1182/blood-2012-07-443325 · Cited by 110
Self-citationSystemic lupus erythematosus and systemic sclerosis: All roads lead to platelets
Scherlinger, M., Guillotin, V., Truchetet, M., Contin‐Bordes, C., Sisirak, V., Duffau, P., Lazaro, E., Richez, C., & Blanco, P. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.01.012 · Cited by 107
Mitochondrial Extrusion through the Cytoplasmic Vacuoles during Cell Death
Nakajima, A., Kurihara, H., Yagita, H., Okumura, K., & Nakano, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802996200 · Cited by 98
Mitochondrial DNA in anucleate human blood cells
Shuster, R. C., Rubenstein, A. J., & Wallace, D. C. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81291-9 · Cited by 97 · cited 1×
“Each platelet contains an average of four mitochondria, which are passed from the megakaryocytes (47).”
BackgroundITIM receptors: more than just inhibitors of platelet activation
Coxon, C. H., Geer, M. J., & Senis, Y. A. (2017) · Blood · doi:10.1182/blood-2016-12-720185 · Cited by 91 · cited 1×
“Similar to most hematopoietic cells, platelets also express immunoreceptor tyrosine-based inhibition motif (ITIM)– containing receptors involved in the attenuation of platelet activation (56).”
BackgroundPlatelet Immunoreceptor Tyrosine-Based Activation Motif (ITAM) Signaling and Vascular Integrity
Boulaftali, Y., Hess, P. R., Kahn, M. L., & Bergmeier, W. (2014) · Circulation Research · doi:10.1161/circresaha.114.301611 · Cited by 87
Crampton, S. P., Morawski, P. A., & Bolland, S. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016451 · Cited by 81 · cited 1×
“One of the major characteristics of SLE is the systemic nature of the inflammation, targeting multiple vital organs among which the most commonly affected are the joints, skin, brain, and the kidneys (4).”
BackgroundToll-like receptors in systemic lupus erythematosus: potential for personalized treatment
Celhar, T., & Fairhurst, A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00265 · Cited by 79
Neutrophil FcγRIIA promotes IgG-mediated glomerular neutrophil capture via Abl/Src kinases
Nishi, H., Furuhashi, K., Culleré, X., Saggu, G., Miller, M. J., Chen, Y., Rosetti, F., Hamilton, S., Yang, L., Pittman, S. P., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94039 · Cited by 76
Becker, Y., Loignon, R.-C., Julien, A.-S., Marcoux, G., Allaeys, I., Lévesque, T., Rollet-Labelle, E., Benk-Fortin, H., Cloutier, N., Melki, I., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40900-3 · Cited by 75
Self-citationAutoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA
Becker, Y., Marcoux, G., Allaeys, I., Julien, A.-S., Loignon, R.-C., Benk-Fortin, H., Rollet-Labelle, E., Rauch, J., Fortin, P. R., & Boilard, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01026 · Cited by 59 · cited 2×
“Moreover, recent investigations confirmed the presence of antimitochondrial antibodies in SLE, some of which recognize the mitochondrial outer membrane or mtDNA (60).”
BackgroundSelf-citationStephan, A., Batinica, M., Steiger, J., Hartmann, P., Zaucke, F., Bloch, W., & Fabri, M. (2016) · Immunology · doi:10.1111/imm.12620 · Cited by 55 · cited 1×
“Platelets did not release LL37, a plasmatic protein known to bind DNA (41), and the concentrations of mtDNA did not correlate with those of LL37 in blood of patients with SLE nor that of lupus-prone mice (fig.”
BackgroundDissecting the Immune Cell Mayhem That Drives Lupus Pathogenesis
Craft, J. E. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002138 · Cited by 53 · cited 1×
“As mtDNA was almost exclusively transported by mitochondrial organelles, this demonstrates an additional means by which mtDNA may be released in SLE (45).”
BackgroundDumestre‐Pérard, C., Clavarino, G., Colliard, S., Cesbron, J.-Y., & Thielens, N. M. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.03.013 · Cited by 47
(1986) · PubMed Central · Cited by 31
Papp, K., Végh, P., Hóbor, R., Szittner, Z., Vokó, Z., Podani, J., Czirják, L., & Prechl, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044824 · Cited by 29
Surface complement C3 fragments and cellular binding of microparticles in patients with SLE
Winberg, L. K., Nielsen, C. H., & Jacobsen, S. (2017) · Lupus Science & Medicine · doi:10.1136/lupus-2016-000193 · Cited by 26 · cited 1×
“In SLE, extracellular vesicles liberated by numerous cellular lineages, such as leukocytes and endothelial cells, are elevated in blood (14) and are targeted by antibodies and complement, pointing to their antigenic load (15, 16).”
BackgroundDistinct proteome pathology of circulating microparticles in systemic lupus erythematosus
Østergaard, O., Nielsen, C. T., Tanassi, J. T., Iversen, L. V., Jacobsen, S., & Heegaard, N. H. H. (2017) · Clinical Proteomics · doi:10.1186/s12014-017-9159-8 · Cited by 26
Anti-native DNA antibodies from autoimmune sera also bind to DNA in mitochondria
Reimer, G., Rubin, R. L., Kotzin, B. L., & Tan, E. M. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.5.2532 · Cited by 22
Research works printed but not linked: 1
- 10.1172/JCI23025 · doi:10.1172/jci23025 · Paper page
Cited by
Mitochondrial control of inflammation
Marchi, S., Guilbaud, E., Tait, S. W. G., Yamazaki, T., & Galluzzi, L. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00760-x · Cited by 1,027
The role of platelets in immune-mediated inflammatory diseases
Scherlinger, M., Richez, C., Tsokos, G. C., Boilard, E., & Blanco, P. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00834-4 · Cited by 346
Recommendations for mitochondria transfer and transplantation nomenclature and characterization
Brestoff, J. R., Singh, K. K., Aquilano, K., Becker, L. B., Berridge, M. V., Boilard, E., Caicedo, A., Crewe, C., Enríquez, J. A., Gao, J., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-024-01200-x · Cited by 170
“By contrast, mtDNA contained in ex-Mito should be susceptible to DNase I digestion after the addition of detergent 122 .”
InfluentialAutoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target
Lou, H., Ling, G. S., & Cao, X. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102861 · Cited by 158
Mitochondria-derived cell-to-cell communication
Dache, Z. A. A., & Thierry, A. R. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112728 · Cited by 172
Metadata
- Authors
- Melki, I., Allaeys, I., Tessandier, N., Lévesque, T., Cloutier, N., Laroche, A., Vernoux, N., Becker, Y., Benk-Fortin, H., Zufferey, A., Rollet-Labelle, E., Pouliot, M., Poirier, G., Patey, N., Belleannee, C., Soulet, D., McKenzie, S. E., Brisson, A., Tremblay, M.-E., Lood, C., Fortin, P. R., & Boilard, E.
- Affiliations
- Centre de Recherche du Centre Hospitalier Universitaire de Québec–Université Laval, Québec, QC G1V 4G2, Canada.
- Centre hospitalier universitaire de Québec (CA)
- Université Laval (CA)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Department of Obstetrics, Gynecology and Reproduction, Centre hospitalier universitaire de Québec–Université Laval et Département de médecine moléculaire de l’Université Laval, Québec, QC G1V 4G2, Canada.
- Thomas Jefferson University (US)
- Centre National de la Recherche Scientifique (FR)
- Axe Neurosciences du Centre de Recherche du Centre Hospitalier Universitaire de Québec–Université Laval et Département de Médecine Moléculaire de l’Université Laval, Québec, QC G1V 4G2, Canada.
- University of Washington (US)
- Corresponding author
- Fortin, Paul R.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2021-02-17
- Volume
- 13
- Issue
- 581
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W3132953708
- Cited by
- 125
- References
- 65
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 26 · 2023: 27 · 2022: 22 · 2021: 10
- FWCI
- 16.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
- Funders
- Lupus Research Alliance
- Canadian Institutes of Health Research
- Arthritis Society
- Canada Research Chairs
- The Fonds de recherche du Québec – Santé
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- systemic lupus erythematosus, platelets, mitochondrial DNA, extracellular mitochondria, autoantigens, platelet secretion, FcγRIIa, immune complexes, autoantibodies, lupus-prone mice, therapeutic target
- MeSH terms
- Animals, Antigen-Antibody Complex, Autoantibodies, Blood Platelets, Humans, Lupus Erythematosus, Systemic, Mitochondria, Receptors, IgG, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.